KPWS
BNTX icon

Kestra Private Wealth Services’s BioNTech BNTX Stock Holding History

Kestra Private Wealth Services’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,659
Closed -$242K – 1624
2025
Q1 		$242K Buy
2,659
+678
+34% +$75.9K ﹤0.01% 1298
2024
Q4 		$226K Buy
+1,981
New +$226K ﹤0.01% 1268
2024
Q2 		– Sell
-5,198
Closed -$480K – 1356
2024
Q1 		$480K Sell
5,198
-3,685
-41% -$353K 0.01% 814
2023
Q4 		$938K Buy
+8,883
New +$895K 0.02% 544
2022
Q2 		– Sell
-1,304
Closed -$222K – 929
2022
Q1 		$222K Buy
+1,304
New +$219K 0.01% 851

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Kestra Private Wealth Services's BNTX Position: Q2 2025 in Review

Kestra Private Wealth Services sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 2,659 shares — an estimated $242K sold.

Kestra Private Wealth Services first reported a position in BNTX in Q1 2022 and held it in 5 quarters. The position peaked at $938K in Q4 2023. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Kestra Private Wealth Services reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Kestra Private Wealth Services sold 2,659 BioNTech shares in Q2 2025, an estimated $242K.
  • Kestra Private Wealth Services first reported a position in BioNTech in Q1 2022 and held it in 5 quarters.
  • Kestra Private Wealth Services's BioNTech position peaked at $938K in Q4 2023.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Kestra Private Wealth Services's 13F filing for Q2 2025, filed 7 Aug 2025.